Perioral dermatitis

HH Science™ Receives Brand's 1st U.S. Patent for Balanced Skin™ Clear Skin Vitamins™

Retrieved on: 
Tuesday, January 23, 2024
Hope, Patient, Nutrient, Vitamin, Melasma, Rosacea, Perioral dermatitis, Skin, MBA, Psoriasis, Smash Mouth, Inflammation, Zinc, Acne, Malnutrition, Dermatitis, Atopic dermatitis, Trial of the century, Antioxidant

MEDINA, Ohio, Jan. 23, 2024 /PRNewswire/ -- HH Science™ is proudly announcing the brand's 1st patent for their Balanced Skin™ Clear Skin Vitamins™. The U.S. Patent and Trademark Office has issued patent No. 11,877,998 which will be officially released on January 23, 2024.

Key Points: 
  • The clinical researcher, Dana Pilz, PA-C, was evaluating whether the Clear Skin Vitamins™ contributed to the overall improvement of acne, melasma, inflammation and perioral dermatitis.
  • All the patients except for two were compliant with taking their Clear Skin Vitamins™ daily.
  • In conclusion, the Clear Skin Vitamins™ did contribute to the overall improvement of acne, melasma, rosacea, atopic dermatitis, inflammation, and perioral dermatitis.
  • "We have numerous claims that have been approved that we can now market as being improved from the daily use of our Clear Skin Vitamins™.

Can I put cortisone on my face? The right advice on creams to fix irritated skin

Retrieved on: 
Tuesday, June 20, 2023
Rosacea, Human, Skin, Vein, Atrophoderma, Education, Face, Solution, Dermatitis, Connective tissue, Telangiectasia, Finger, Cortisone, Acne, Research, Psoriasis, Capillary, Perioral dermatitis, Hydrocortisone, Erythema, Patient, Risk, Steroid, Vitiligo, Sunburn, Glycosaminoglycan, Groin, Maharashtra University of Health Sciences, News, Red, Sulfur, Vaccine, Dietary supplement, Mineral oil, Cosmetics, Topical medication

Topical corticosteroids, also referred to as corticosteroids or cortisone, are the go-to treatment for many skin disorders including eczema, dermatitis and psoriasis.

Key Points: 
  • Topical corticosteroids, also referred to as corticosteroids or cortisone, are the go-to treatment for many skin disorders including eczema, dermatitis and psoriasis.
  • They can be found in various forms such as creams, ointments, and solutions.
  • Topical corticosteroids come in different strengths, from mild (such as 0.5% Hydrocortisone, available over the counter) to very potent prescription formulations.

‘Use sparingly’

    • Such warnings ignore the fact many patients are prescribed modest-strength topical steroids, which are safe and effective when used properly.
    • From the patient’s perspective, the current warnings lump all steroids together regardless of their potential for side effects.

Mixed messages

    • Or hit the problem hard with a stronger concentration for less time?
    • If cortisone is extensively used, it is advised adults and children should be examined yearly for side effects.
    • Skin atrophy (or deterioration) is the most common side effect of topical corticosteroids and manifests as tiny degenerative alterations within a few weeks.

Skin thinning

    • Repeated use in the same spot on the body results in alterations to the skin’s connective tissue and epidermal thinning.
    • That can result in lax, translucent, wrinkled skin as well as striae (stretch marks), fragility, hypo-pigmentation (fading) and the prominence of underlying veins.
    • The good news is that once topical corticosteroids are stopped, short-term atrophy from treatment can be reversed, although skin normalisation may take months.

Can you use it safely on your face?

    • Using strong cortisone creams or ointments on the face can lead to steroid dependence.
    • Topical steroids on the face can cause symptoms sometimes referred to as “red face syndrome”, dermatitis rosaceaformis steroidica or steroid addiction.
    • And stopping steroid use on the face after an extended period can have considerable rebound effects including erythema (redness), burning and scaling.

The bottom line

    • To avoid skin damage, corticosteroids should only be used on skin affected by a skin disease.
    • Finally, treatment should be customised based on the person’s symptoms, the body parts affected and how long treatment might be required.
    • This article reflects the views of the author and
      should not be construed to represent views or
      policies.

FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis

Retrieved on: 
Tuesday, September 21, 2021
Tablet, Food, Therapy, Miliaria, Rosacea, Irritation, Steroid, Hyperglycemia, Prevalence, BurNIng, Compliance, Itch, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Torso, FDA, Patient, Adolescence, Folliculitis, Body surface area, Scalp, Adult, Allergic contact dermatitis, Doxycycline, Immune system, Hypopigmentation, Glycosuria, Phase, CEO, Telangiectasia, Company, Ageing, Acne, Greasy hair, Dry, Hospira, ASX, Risk, Cushing's syndrome, Perioral dermatitis, Dermatology, Atrophy, Cell, Safety, Infection, Glaucoma, National Psoriasis Foundation, Ulobetasol, HPA, Time, Skin, Pharmaceutical industry, Cosmetics, Generic drug

LEXETTE, a super potent topical corticosteroid,is now approved for the treatment of plaque psoriasis in patients aged 12 years and older.

Key Points: 
  • LEXETTE, a super potent topical corticosteroid,is now approved for the treatment of plaque psoriasis in patients aged 12 years and older.
  • The FDA approved LEXETTE in 2018 based on evidence from two multicentre, randomized, double-blind, vehicle-controlled studies (n=560) in patients with plaque psoriasis involving between 2% to 12% body surface area.
  • LEXETTE (halobetasol propionate) foam is a potent corticosteroid indicated for the topical treatment of plaque psoriasis in patients twelve years of age and older.
  • LEXETTE foam was evaluated for the treatment of moderate to severe plaque psoriasis in two multicentre, randomised, double-blind, vehicle-controlled studies.